Description
Esomeprazole-based high-dose dual therapy achieved superior H. pylori eradication (>90%) compared to rabeprazole in a real-world Taiwanese study.
Select Content Type
Resources
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Detail Image
Book Detail
Upload PDF
Drug Update_Sept2025.pdf
(229.01 KB)
Actions
Download in App
Countries of release
Angola
Central African Republic (CAR)
Democratic Republic of the Congo (DRC)
Ghana
India
Kenya
Nigeria
UAE
Zambia
IS_Ebsco
false